Whittier Trust CO Of Nevada Inc Recursion Pharmaceuticals, Inc. Transaction History
Whittier Trust CO Of Nevada Inc
- $4.59 Billion
- Q3 2025
A detailed history of Whittier Trust CO Of Nevada Inc transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 1,000 shares of RXRX stock, worth $4,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$4,330% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
304MCall Options Held
7.56MPut Options Held
4.72M-
Vanguard Group Inc Valley Forge, PA39.8MShares$172 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.5MShares$145 Million1.15% of portfolio
-
Baillie Gifford & CO24MShares$104 Million0.09% of portfolio
-
State Street Corp Boston, MA18.3MShares$79.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$75 Million0.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $781M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...